CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 771 enrolled
Drug / intervention
Comparison between GenePOC PCR and Reference Methoddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02718157
NCT02718157N/ACompleted

Prospective Study for Clinical Validation of the Molecular-Based GenePOC GBS Assay for the Detection of the Cfb Gene From Streptococcus Agalactiae Strains in Vaginal/Rectal Swab Specimens, After Lim Broth Enrichment, From Pregnant Women

Meridian Bioscience, Inc.·interventional·Posted Mar 24, 2016·Updated May 3, 2021

In Brief

A clinical study evaluating Comparison between GenePOC PCR and Reference Method for Streptococcus Agalactiae Infection. Completed, enrolled 771 participants across 4 sites in 2 countries.

Detailed Summary

The primary purpose of this clinical investigation is to verify the performance of the GenePOC GBS Assay on the GenePOC Instrument. This will be achieved by comparing the Assay to the a Culture, a conventional method for detection of Streptococcus agalactiae in vaginal/rectal swab specimens from antepartum women.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada, United States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 24, 2016
Enrollment StartAug 10, 2016
Primary CompletionFeb 7, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 10.3 years ago

Interventions

Comparison between GenePOC PCR and Reference Methoddevice

Antepartum women swab specimen incubated in Lim Broth will be tested with the GenePOC GBS test on the GenePOC Instrument. The results will be compared to Reference Method defined as incubated Lim broth subcultured onto blood agar plate for observation of a Streptococcus agalactiae strain.